The role of glucocorticoid in SIRP alpha and SHP-1 gene expression in AIHA patients
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
20/10/2012
20/10/2012
2009
|
Resumo |
The aim of this work was to evaluate the regulation of SIRP alpha, an inhibitory phagocyte receptor, and the phosphatase SHP-1 in monocytes of patients with autoimmune hemolytic anemia, and the role of dexamethasone on SIRP alpha and SHP-1 gene expression and erythrophagocytosis in vitro. SIRP alpha and SHP-1 expression was higher in monocytes from AIHA patients compared with normal, returning to normal after glucocorticoid therapy. SIRP alpha and SHP-1 mRNA expression was upregulated in healthy monocytes treated with dexamethasone compared with basal; however, the erythrophagocytic ability was not altered. Our results point to a minor role of SIRP alpha and SHP-1 in determining AIHA.</. National Council for Technological and Scientific Development (CNPq)[141602/2005-8] Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) |
Identificador |
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, v.31, n.4, p.636-640, 2009 0892-3973 http://producao.usp.br/handle/BDPI/28288 10.3109/08923970902939256 |
Idioma(s) |
eng |
Publicador |
TAYLOR & FRANCIS INC |
Relação |
Immunopharmacology and Immunotoxicology |
Direitos |
restrictedAccess Copyright TAYLOR & FRANCIS INC |
Palavras-Chave | #AUTOIMMUNE HEMOLYTIC-ANEMIA #IN-VITRO #PHAGOCYTOSIS #MONOCYTES #ERYTHROPHAGOCYTOSIS #CORTICOSTEROIDS #HYDROCORTISONE #MACROPHAGES #THERAPY #SHPS-1 #Immunology #Pharmacology & Pharmacy #Toxicology |
Tipo |
article original article publishedVersion |